Oral and Topical Sirolimus for Vascular Anomalies: A Multicentre Study and Review
Vascular anomalies (VAs) may be associated with significant morbidity and mortality. The aim of this study was to evaluate the efficacy and safety of sirolimus (rapamycin) in the treatment of children and young adults with complicated VAs. A retrospective chart was created that included 19 patients...
Main Authors: | Shira Sandbank, Vered Molho-Pessach, Adam Farkas, Aviv Barzilai, Shoshana Greenberger |
---|---|
Format: | Article |
Language: | English |
Published: |
Society for Publication of Acta Dermato-Venereologica
2019-08-01
|
Series: | Acta Dermato-Venereologica |
Subjects: | |
Online Access: |
https://www.medicaljournals.se/acta/content/html/10.2340/00015555-3262
|
Similar Items
-
Efficacy and Tolerance of Sirolimus (Rapamycin) for Extracranial Arteriovenous Malformations in Children and Adults
by: Romain Gabeff, et al.
Published: (2019-09-01) -
Efficacy of Sirolimus in Patients Requiring Tracheostomy for Life-Threatening Lymphatic Malformation of the Head and Neck: A Report From the European Reference Network
by: Annegret Holm, et al.
Published: (2021-09-01) -
Sirolimus in the treatment of kaposiform lymphangiomatosis
by: Jiangyuan Zhou, et al.
Published: (2021-06-01) -
Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study
by: Jennifer Hammer, et al.
Published: (2018-10-01) -
Treatment of voluminous and complicated superficial slow-flow vascular malformations with sirolimus (PERFORMUS): protocol for a multicenter phase 2 trial with a randomized observational-phase design
by: Annabel Maruani, et al.
Published: (2018-06-01)